Age at symptom onset and death and disease duration in genetic frontotemporal dementia : an international retrospective cohort study

Background: Frontotemporal dementia is a heterogenous neurodegenerative disorder, with about a third of cases being genetic. Most of this genetic component is accounted for by mutations in GRN, MAPT, and C9orf72. In this study, we aimed to complement previous phenotypic studies by doing an international study of age at symptom onset, age at death, and disease duration in individuals with mutations in GRN, MAPT, and C9orf72. Methods: In this international, retrospective cohort study, we collected data on age at symptom onset, age at death, and disease duration for patients with pathogenic mutations in the GRN and MAPT genes and pathological expansions in the C9orf72 gene through the Frontotemporal Dementia Prevention Initiative and from published papers. We used mixed effects models to explore differences in age at onset, age at death, and disease duration between genetic groups and individual mutations. We also assessed correlations between the age at onset and at death of each individual and the age at onset and at death of their parents and the mean age at onset and at death of their family members. Lastly, we used mixed effects models to investigate the extent to which variability in age at onset and at death could be accounted for by family membership and the specific mutation carried. Findings: Data were available from 3403 individuals from 1492 families: 1433 with C9orf72 expansions (755 families), 1179 with GRN mutations (483 families, 130 different mutations), and 791 with MAPT mutations (254 families, 67 different mutations). Mean age at symptom onset and at death was 49\ub75 years (SD 10\ub70; onset) and 58\ub75 years (11\ub73; death) in the MAPT group, 58\ub72 years (9\ub78; onset) and 65\ub73 years (10\ub79; death) in the C9orf72 group, and 61\ub73 years (8\ub78; onset) and 68\ub78 years (9\ub77; death) in the GRN group. Mean disease duration was 6\ub74 years (SD 4\ub79) in the C9orf72 group, 7\ub71 years (3\ub79) in the GRN group, and 9\ub73 years (6\ub74) in the MAPT group. Individual age at onset and at death was significantly correlated with both parental age at onset and at death and with mean family age at onset and at death in all three groups, with a stronger correlation observed in the MAPT group (r=0\ub745 between individual and parental age at onset, r=0\ub763 between individual and mean family age at onset, r=0\ub758 between individual and parental age at death, and r=0\ub769 between individual and mean family age at death) than in either the C9orf72 group (r=0\ub732 individual and parental age at onset, r=0\ub736 individual and mean family age at onset, r=0\ub738 individual and parental age at death, and r=0\ub740 individual and mean family age at death) or the GRN group (r=0\ub722 individual and parental age at onset, r=0\ub718 individual and mean family age at onset, r=0\ub722 individual and parental age at death, and r=0\ub732 individual and mean family age at death). Modelling showed that the variability in age at onset and at death in the MAPT group was explained partly by the specific mutation (48%, 95% CI 35\u201362, for age at onset; 61%, 47\u201373, for age at death), and even more by family membership (66%, 56\u201375, for age at onset; 74%, 65\u201382, for age at death). In the GRN group, only 2% (0\u201310) of the variability of age at onset and 9% (3\u201321) of that of age of death was explained by the specific mutation, whereas 14% (9\u201322) of the variability of age at onset and 20% (12\u201330) of that of age at death was explained by family membership. In the C9orf72 group, family membership explained 17% (11\u201326) of the variability of age at onset and 19% (12\u201329) of that of age at death. Interpretation: Our study showed that age at symptom onset and at death of people with genetic frontotemporal dementia is influenced by genetic group and, particularly for MAPT mutations, by the specific mutation carried and by family membership. Although estimation of age at onset will be an important factor in future pre-symptomatic therapeutic trials for all three genetic groups, our study suggests that data from other members of the family will be particularly helpful only for individuals with MAPT mutations. Further work in identifying both genetic and environmental factors that modify phenotype in all groups will be important to improve such estimates. Funding: UK Medical Research Council, National Institute for Health Research, and Alzheimer's Society

Temporal Genetic Structure Of Major Dengue Vector Aedes Aegypti From Manaus, Amazonas, Brazil

In recent years, high levels of Aedes aegypti infestation and several dengue outbreaks with fatal outcome cases have been reported in Manaus, State of Amazonas, Brazil. This situation made it important to understand the genetic structure and gene flow patterns among the populations of this vector in Manaus, vital pieces of information for their management and development of new control strategies. In this study, we used nine microsatellite loci to examine the effect of seasonality on the genetic structure and gene flow patterns in Ae. aegypti populations from four urban neighborhoods of Manaus, collected during the two main rainy and dry seasons. All loci were polymorphic in the eight samples from the two seasons, with a total of 41 alleles. The genetic structure analyses of the samples from the rainy season revealed genetic homogeneity and extensive gene flow, a result consistent with the abundance of breeding sites for this vector. However, the samples from the dry season were significantly structured, due to a reduction of Ne in two (Praça 14 de Janeiro and Cidade Nova) of the four samples analyzed, and this was the primary factor influencing structure during the dry season. Genetic bottleneck analyses suggested that the Ae. aegypti populations from Manaus are being maintained continuously throughout the year, with seasonal reduction rather than severe bottleneck or extinction, corroborating previous reports. These findings are of extremely great importance for designing new dengue control strategies in Manaus. © 2014 Elsevier B.V.13418088Apostol, B.L., Black, I.V., Reiter, W.C., Miller, P.B.R., Use of randomly amplified polymorphic DNA amplified by polymerase chain reaction markers to estimate the number of Aedes aegypti families at oviposition sites in San Juan, Puerto Rico (1994) Am. J. Trop. Med. Hyg., 51, pp. 89-97Bastos, M.S., Figueiredo, R.M.P., Ramasawmy, R., Itapirema, E., Gimaque, J.B.L., Santos, L.O., Figueiredo, L.T.M., Mourão, M.P.G., Simultaneous circulation of all four dengue serotypes in Manaus, State of Amazonas Brazil, in 2011 (2012) Rev. Soc. Brasil. Med. Trop., 45, pp. 393-394Brown, J.E., McBride, C.S., Johnson, P., Ritchie, S., Paupy, C., Bossin, H., Lutomiah, J., Powell, C.J.R., Worldwide patterns of genetic differentiation imply multiple "domestications" of Aedes aegypti, a major vector of human diseases (2010) Proc. R. Soc. B, p. 2469Campos, M., Spenassatto, C., Macoris, M.L.G., Paduan, K.S., Pinto, J., Ribolla, P.E.M., Seasonal population dynamics and the genetic structure of the mosquito vector Aedes aegypti in São Paulo, Brazil (2012) Ecol. Evol., 2, pp. 2794-2802Chambers, E.W., Meece, J.K., McGowan, J.A., Lovin, D.D., Hemme, R.R., Chadee, D.D., McAbee, K., Severson, D.W., Microsatellite isolation and linkage group identification in the yellow fever mosquito Aedes aegypti (2007) J. Hered., 98, pp. 202-210Collins, F.H., Kamau, L., Ranson, H.A., Vulule, J.M., Molecular entomology and prospects for malaria control (2000) Bull. World Health Organ., 78, pp. 1412-1423Collins, F.H., Mendez, M.A., Rasmussen, M.O., Mehaffey, P.C., Besansky, N.J., Finnerty, V., A ribossomal RNA gene probe differentiations member species of the Anopheles gambiae complex (1987) Am. J. Trop. Med. Hyg., 37, pp. 37-41Cornuet, J.M., Luikart, G., Description and power analysis of two tests for detecting recent population bottlenecks from allele frequency data (1996) Genetics, 144, pp. 2001-2014Costa-Ribeiro, M.C.V., Lourenço-de-Oliveira, R., Failloux, A.B., Geographic and temporal genetic patterns of Aedes aegypti populations in Rio de Janeiro, Brazil (2006) Trop. Med. Int. Health, 2, pp. 1276-1285Creste, S., Tulmann Neto, A., Figueira, A., Detection of single sequence repeat polymorphisms in denaturing polyacrylamide sequencing gels by silver staining (2001) Plant Mol. Biol., 19, pp. 299-306Evanno, G., Regnaut, S., Goudet, J., Detecting the number of clusters of individuals using the software Structure: a simulation study (2005) Mol. Ecol., 14, pp. 2611-2620Excoffier, L., Laval, G., Schneider, S., (2006) An Integrated Software Package for Population Genetics Data Analysis, Version 3.01, , http://www.cmpg.unibe.ch/software/arlequin3, Computational and Molecular Population Genetics Lab. Institute of Zoology, University of Berne, Switzerland, Available fromFailloux, A.-B., Vazeille, M., Rodhain, F., Geographic genetic variation in populations of the dengue virus vector Aedes aegypti (2002) J. Mol. Evol., 55, pp. 653-663Forattini, O.P., (2002) Culicidologia Médica, Volume 2: Identificação, Biologia, Epidemiologia, p. 860. , Editora da Universidade de São Paulo, São Paulo, BrasilGoudet, J., FSTAT, version 2.9.3.2. A computer program to calculate F-statistics (1995) J. Hered., 86, pp. 485-486Gubler, D.J., Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem (1997) Dengue and Dengue Hemorrhagic Fever, pp. 1-23. , CAB International, New York, D.J. Gubler, G. Kino (Eds.)Gubler, D.J., Epidemic dengue/dengue hemorrhagic fever as a public health, social, and economic problem in the 21st century (2002) Trends Microbiol., 10, pp. 100-103Gutiérrez, L.A., Gómes, G.G., González, J.J., Castro, M.I., Luckhart, S., Conn, J.E., Correa, M.M., Microgeographic genetic variation of the malaria vector Anopheles darlingi Root (Diptera: Culicidae) from Córdoba and Antioquia, Colombia (2010) Am. J. Trop. Med. Hyg., 83, pp. 38-47Hlaing, T., Tun-Lin, W., Somboon, P., Socheat, D., Setha, T., Min, S., Thaung, S., Walton, C., Spatial genetic structure of Aedes aegypti mosquitoes in mainland Southeast Asia (2010) Evol. Applicat., 3, pp. 319-339Holm, S., A simple sequential rejective multiple test procedure (1979) Scand. J. Stat., 6, pp. 65-70Huber, K., Loan, L.L., Hoang, T.H., Ravel, S., Rodhain, F., Failloux, A.-B., Genetic differentiation of the dengue vector, Aedes aegypti (Ho Chi Minh City Vietnam) using microsatellite markers (2002) Mol. Ecol., 11, pp. 1629-1635Huber, K., Loan, L.L., Hoang, T.H., Tien, T.K., Rodhain, F., Failloux, A.-B., Temporal genetic variation in Aedes aegypti populations in Ho Chi Minh City (Vietnam) (2002) Heredity, 89, pp. 7-14Huber, K., Ba, Y., Dia, I., Mathiot, C., Sall, A.A., Diallo, M., Aedes aegypti in Senegal: genetic diversity and genetic structure of domestic and sylvatic populations (2008) Am. J. Trop. Med. Hyg., 79, pp. 218-229(2013) Instituto Brasileiro de Geografia e Estatística, , www.ibge.gov.br/home/estatistica/pesquisas/indicadores.php, IBGE Available at: (accessed 01.09.13)Lima-Júnior, R.S., Scarpassa, V.M., Evidence of two lineages of the dengue vector Aedes aegypti in the Brazilian Amazon based on mitochondrial DNA ND4 gene sequences (2009) Genet. Mol. Biol., 32, pp. 414-422Lourenço-de-Oliveira, R., Vazeille, M., Filippis, A.M.B., Failloux, A.-B., Oral susceptibility to yellow fever virus of Aedes aegypti from Brazil (2002) Mem. Inst. Oswaldo Cruz, 97, pp. 437-439Lourenço-de-Oliveira, R., Vazeille, M., Filippis, A.M.B., Failloux, A.-B., Aedes aegypti in Brazil: genetically differentiated populations with high susceptibility to dengue and yellow fever viruses (2004) Trans. Royal Soc. Trop. Med. Hyg., 98, pp. 43-54McCauley, D.E., Genetics consequence of local population extinction and recolonization (1991) Trends Ecol. Evol., 6, pp. 5-8Midega, J.T., Muturi, E.J., Baliraine, F.N., Mbogo, C.M., Githure, J., Beier, J.C., Yan, G., Population structure of Anopheles gambiae along the Kenyan coast (2010) Acta Trop., 114, pp. 103-108Miller, M., (1997) A Windows Program for the Analysis of Allozyme and Molecular Population Genetics Data (TFPGA), , Department of Biological Sciences, Northern Arizona University, Flagstaff, USAMoreira, L.A., Iturbe-Ormaetxe, I., Jeffery, J.A., Lu, G., Pyke, A.T., Hedges, L.M., Rocha, B.C., O'Neill, S.L., A Wolbachia symbiont in Aedes aegypti limits infection with Dengue, Chikungunya, and Plasmodium (2009) Cell, 139, pp. 1268-1278(2012) Ministério da Saúde. Situação da Dengue no Brasil, Brasília, DF, Brazil, , http://portal.saude.gov.br/portal/arquivos/pdf/boletimdengue, MS Available at: (accessed 02.03.13)Neis Ribeiro, A., Gassen Balsan, L., Moura, G., (2013) Análise das políticas públicas de combate à dengue En Contribuciones a lãs Ciencias Sociales, , www.eumed.net/rev/cccss/24/politicas-publicas-dengue.html, Available atPark, S.D.E., (2001) MSTools, version 3, , http://www.acer.gen.tcd.ie/sdepark/ms-toolkit, Available at: (accessed 04.04.10)Paupy, C., Vazeille-Falcoz, M., Mousson, L., Rodhain, F., Failloux, A.-B., Aedes aegypti in Tahiti and Moorea (French Polynesia): isoenzymes differentiation in the mosquito population according to human population density (2000) Am. J. Trop. Med. Hyg., 62, pp. 217-224Paupy, C., Chantha, N., Reynes, J.M., Failloux, A.-B., Factors influencing the population structure of Aedes aegypti from the many cities in Cambodia (2005) Heredity, 95, pp. 144-147Paupy, C., Brengues, C., Kamgang, B., Herve, J.-P., Fontenille, D., Simard, F., Gene Flow Between Domestic and Sylvan Populations of Aedes aegypti (Diptera: Culicidae) in North Cameroon (2008) J. Med. Entomol., 45, pp. 391-400Paupy, C., Le Goff, G., Brengues, C., Guerra, M., Revollo, J., Simon, Z.B., Hervé, J.-P., Fontenille, D., Genetic structure and phylogeography of Aedes aegypti, the dengue and yellow-fever mosquito vector in Bolivia (2012) Infect. Genet. Evol., 12, pp. 1260-1269Peel, D., Ovenden, J., Peel, S., NeEstimator: Software for Estimating Effective Population Size: Queensland Government (2004) Department of Primary Industries and FisheriesPinheiro, V.C.S., Tadei, P.W., Frequency, diversity, and productivity study on the Aedes aegypti most preferred containers in the city of Manaus, Amazonas, Brazil (2002) Rev. Inst. Med. Trop. São Paulo, 44, pp. 245-250Pritchard, J.K., Stephens, M., Donnelly, P., Inference of population structure using multilocus genotype data (2000) Genetics, 155, pp. 945-959Ríos-Velásquez, C.M., Codeço, C.T., Honório, N.A., Sabroza, P.S., Moresco, M., Cunha, I.C.L., Levino, A., Luz, S.L.B., Distribution of dengue vectors in neighborhoods with different urbanization types of Manaus, state of Amazonas, Brazil (2007) Mem. Inst. Oswaldo Cruz, 102, pp. 617-623Ravel, S., Monteny, N., Olmos, D.V., Verduro, J.E., Cuny, G., A preliminary study of the population genetics of Aedes aegypti (Diptera: Culicidae) from Mexico using microsatellite and AFLP markers (2001) Acta Trop., 78, pp. 241-250Ravel, S., Hervé, J.P., Diarrassouba, S., Cuny, G., Microsatellite markers for population genetic studies in Aedes aegypti (Diptera: Culicidae) from CÔte d'Ivoire: evidence for a microgeographic genetic differentiation of mosquitos from Bouaké (2002) Acta Trop., 82, pp. 39-49Rousset, F., Genepop'007: a complete reimplementation of the Genepop software for Windows and Linux (2008) Mol. Ecol. Res., 8, pp. 103-106Scarpassa, V.M., Conn, J.E., Population genetic structure of the major malaria vector Anopheles darlingi (Diptera: Culicidae) from the Brazilian Amazon, using microsatellite markers (2007) Mem. Inst. Oswaldo Cruz, 102, pp. 319-327Scarpassa, V.M., Cardoza, T.B., Cardoso-Júnior, R.P., Population genetics and phylogeography of Aedes aegypti (Diptera: Culicidae) from Brazil (2008) Am. J. Trop. Med. Hyg., 78, pp. 895-903Slotman, M.A., Kelly, N.B., Harrington, L.C., Kitthawee, S., Jones, J.W., Scott, T.W., Caccone, A., Powell, J.R., Polymorphic microsatellite markers for studies of Aedes aegypti (Diptera: Culicidae), the vector of dengue and yellow fever (2007) Mol. Ecol. Notes, 7, pp. 168-171Tabachnick, W.J., Powell, J.R., A world-wide survey of genetic variation in the yellow fever mosquito Aedes aegypti (1979) Genet. Res., 34, pp. 215-229Teixeira, M.G., Costa, M.C.N., Barreto, F., Barreto, M.L., Dengue: twenty-five years since reemergence in Brazil (2009) Cad. Saúde Pública, 25, pp. S7-S18Van Oosterhout, C., Hutchinson, W.F., Willis, D.P.M., Shipley, P., Micro-checker: software for identifying and correcting genotyping errors in microsatellite data (2004) Mol. Ecol. Notes, 4, pp. 535-538Yébakima, A., Charles, C., Mousson, L., Vazeille, M., Yp-Tcha, M.M., Failloux, A.-B., Genetic heterogeneity of the dengue vector Aedes aegypti in Martinique (2004) Trop. Med. Int. Health, 9, pp. 582-587Wallis, G.P., Tabachnick, W.J., Powell, J.R., Macrogeographic genetic variation in a human commensal: Aedes aegypti, the yellow fever mosquito (1983) Genet. Res., 41, pp. 241-258(2007) Impact of Dengue, , www.who.int/csr/disease/dengue/impact/en/index.htm, WHO - World Health Organization Available at(2010) First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases, p. 172. , http://www.who.int/neglected_diseases, WHO - World Health Organization World Health Organization, Geneva, Available at: (accessed in 03.07.2012

Central precocious puberty caused by mutations in the imprinted gene MKRN3

Background: The onset of puberty is first detected as an increase in pulsatile secretion of gonado-tropin-releasing hormone (GnRH). Early activation of the hypothalamic-pituitary-gonadal axis results in central precocious puberty. The timing of pubertal development is driven in part by genetic factors, but only a few, rare molecular defects associated with central precocious puberty have been identified. Methods: We performed whole-exome sequencing in 40 members of 15 families with central precocious puberty. Candidate variants were confirmed with Sanger sequencing. We also performed quantitative real-time polymerase-chain-reaction assays to determine levels of messenger RNA (mRNA) in the hypothalami of mice at different ages. Results: We identified four novel heterozygous mutations in MKRN3, the gene encoding makorin RING-finger protein 3, in 5 of the 15 families; both sexes were affected. The mutations included three frameshift mutations, predicted to encode truncated proteins, and one missense mutation, predicted to disrupt protein function. MKRN3 is a paternally expressed, imprinted gene located in the Prader-Willi syndrome critical region (chromosome 15q11-q13). All affected persons inherited the mutations from their fathers, a finding that indicates perfect segregation with the mode of inheritance expected for an imprinted gene. Levels of Mkrn3 mRNA were high in the arcuate nucleus of prepubertal mice, decreased immediately before puberty, and remained low after puberty. Conclusions: Deficiency of MKRN3 causes central precocious puberty in humans. Copyright © 2013 Massachusetts Medical Society

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically

Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery

Background: Ileus is common after elective colorectal surgery, and is associated with increased adverse events and prolonged hospital stay. The aim was to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs) for reducing ileus after surgery. Methods: A prospective multicentre cohort study was delivered by an international, student- and trainee-led collaborative group. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The primary outcome was time to gastrointestinal recovery, measured using a composite measure of bowel function and tolerance to oral intake. The impact of NSAIDs was explored using Cox regression analyses, including the results of a centre-specific survey of compliance to enhanced recovery principles. Secondary safety outcomes included anastomotic leak rate and acute kidney injury. Results: A total of 4164 patients were included, with a median age of 68 (i.q.r. 57\u201375) years (54\ub79 per cent men). Some 1153 (27\ub77 per cent) received NSAIDs on postoperative days 1\u20133, of whom 1061 (92\ub70 per cent) received non-selective cyclo-oxygenase inhibitors. After adjustment for baseline differences, the mean time to gastrointestinal recovery did not differ significantly between patients who received NSAIDs and those who did not (4\ub76 versus 4\ub78 days; hazard ratio 1\ub704, 95 per cent c.i. 0\ub796 to 1\ub712; P = 0\ub7360). There were no significant differences in anastomotic leak rate (5\ub74 versus 4\ub76 per cent; P = 0\ub7349) or acute kidney injury (14\ub73 versus 13\ub78 per cent; P = 0\ub7666) between the groups. Significantly fewer patients receiving NSAIDs required strong opioid analgesia (35\ub73 versus 56\ub77 per cent; P < 0\ub7001). Conclusion: NSAIDs did not reduce the time for gastrointestinal recovery after colorectal surgery, but they were safe and associated with reduced postoperative opioid requirement